nizatidine has been researched along with Disease Models, Animal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Ankavay, M; Bandiera, S; Bardeesy, N; Baumert, TF; Bian, CB; Chung, RT; Cocquerel, L; Croonenborghs, T; Crouchet, E; Duong, FHT; Durand, SC; El Saghire, H; Felli, E; Fernández-Vaquero, M; Fuchs, BC; Fujiwara, N; González-Motos, V; Goossens, N; Gunasekaran, G; Heide, D; Heikenwälder, M; Hetzer, J; Heydmann, L; Higashi, T; Hirschfield, H; Hoshida, Y; Jühling, F; Kiani, K; Kim, RS; Koh, AP; Li, S; Lupberger, J; Mahajan, M; Masia, R; Nair, VD; Nakagawa, S; Ono, A; Oudot, MA; Pessaux, P; Pochet, N; Ponsolles, C; Qian, T; Regev, A; Riedl, T; Roehlen, N; Rozenblatt-Rosen, O; Sanchez, R; Saviano, A; Schaeffer, E; Schuppan, D; Schuster, C; Schwartz, ME; Shalek, AK; Sojoodi, M; Song, WM; Straub, BK; Subramanian, A; Sun, X; Tanabe, KK; Thumann, C; Venkatesh, A; Verrier, ER; Wei, L; Zeisel, MB; Zhu, S | 1 |
| Chen, R; Wang, B; Wang, M; Wang, S; Wu, B; Xue, J | 1 |
| Bansal, D; Dubey, N; Ganeshpurkar, A; Jain, A; Pandey, V | 1 |
4 other study(ies) available for nizatidine and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery.
Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Chemoprevention; Cohort Studies; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Drug Discovery; Gene Expression Regulation, Neoplastic; HEK293 Cells; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Immunologic Surveillance; Inflammation; Liver; Liver Cirrhosis; Liver Neoplasms; Macrophages; Male; Mice, Knockout; Models, Biological; Nizatidine; Prognosis; Signal Transduction; Transcriptome | 2021 |
Nizatidine, a small molecular compound, enhances killed H5N1 vaccine cell-mediated responses and protects mice from lethal viral challenge.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Disease Models, Animal; Female; Immunity, Cellular; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Mice, Inbred C57BL; Nizatidine; Orthomyxoviridae Infections; Survival Analysis; T-Lymphocytes; Th1 Cells; Th2 Cells; Vaccines, Inactivated | 2014 |
Formulation and characterization of floating microballoons of nizatidine for effective treatment of gastric ulcers in murine model.
Topics: Animals; Anti-Ulcer Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Female; Male; Microscopy, Electron, Scanning; Microspheres; Nizatidine; Rats; Stomach Ulcer; Surface Properties | 2015 |